"10.1371_journal.pone.0100722","plos one","2014-06-26T00:00:00Z","Romina Camilli; Brady L Spencer; Monica Moschioni; Vittoria Pinto; Francesco Berti; Moon H Nahm; Annalisa Pantosti","Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit√†, Rome, Italy; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Novartis Vaccines & Diagnostics, Siena, Italy; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America","Conceived and designed the experiments: AP RC FB MHN. Performed the experiments: RC BLS MM VP FB. Analyzed the data: RC BLS MM VP FB AP MHN. Contributed reagents/materials/analysis tools: AP FB MHN. Wrote the manuscript: RC AP FB MHN.","This study was partly funded by Novartis. MM, FB, and VP are currently employed at Novartis Vaccines and Diagnostics, Siena Italy. University of Alabama at Birmingham (UAB) has intellectual property rights on monoclonal antibodies and MHN and BLS are UAB employees. There are no patents, products in developments or marketed products on this specific subject. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","06","Romina Camilli","RC",7,TRUE,4,5,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
